Specialist patient recruitment agency Havas Lynx Faze, from the leading global healthcare communications agency Havas Lynx Group, has spent months speaking to patients and leaders across the pharmaceutical industry to better understand what’s working – and what’s not – in clinical trials.
Clinical research is essential in helping us find out if new therapies really do work and if they can make a difference to patients’ lives.
But with over 300,000 trials looking for around 44 million patients, conducting clinical research is becoming increasingly difficult. We know there are patients out there, often searching desperately for new options or alternatives that they haven’t already tried.
Patient centricity is a misused buzzword to signpost all manner of token efforts, but the real winners will be those who embrace it throughout their organisation. Not just because it’s the right thing to do, but because it is the only way to fix a broken model.
That is the clear message from Havas Lynx Group as it marks Clinical Trials Day (May 20th) with the launch of a new white paper designed to provoke conversation and offer potential solutions to a problem that is costing lives and the sector more than $40bn every year.
Clinical trial recruitment is in crisis, with 80% of trials failing to recruit the required number of patients on time. There are few instances in life where we are happy achieving a score of two out of ten, so why are we allowing this to happen in an industry where the end result is a delay in getting life-changing treatments to patients (not to mention billions of dollars of additional costs)?